Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0197-4580(99)00103-7PMID 10794845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity.

  1997cited by this paper
• Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.

  1997cited by this paper
• Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury.

  1997cited by this paper
• Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.

  1996cited by this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Brain Expression of Apolipoproteins E, J, and A‐I in Alzheimer's Disease

  1996cited by this paper
• Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid

  1995cited by this paper
• Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid.

  1995cited by this paper
• Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.

  1995influential reference
• Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.

  1995cited by this paper
• Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease.

  1995cited by this paper
• The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

  1994cited by this paper
• Low Levels of Serum Apolipoprotein AI and AII in Senile Dementia

  1994cited by this paper
• Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.

  1994cited by this paper
• Structure and stability of apolipoprotein J-containing high-density lipoproteins.

  1992cited by this paper
• Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis.

  1990cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.

  1989cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

  1987cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975influential reference

• Oxysterol-binding protein ORP6 regulates lipid metabolism and brain Aβ production

  2025cites this paper
• The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization

  2025cites this paper
• High-density lipoprotein mimetic peptide 4F ameliorates APOE4-associated lipid dysfunction in primary and iPSC-derived astrocytes and cerebral organoids

  2025cites this paper
• Alterations of Apolipoprotein A1, E, and J Genes in the Frontal Cortex in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival

  2025cites this paper
• Joint multi-omics profiling of brain and body health in aging

  2025cites this paper
• Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer's Disease: A Cross-sectional Study.

  2025cites this paper
• The Role of APOA-I in Alzheimer’s Disease: Bridging Peripheral Tissues and the Central Nervous System

  2025cites this paper
• Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge

  2025cites this paper
• Proteome-Based Biomarkers for Alzheimer’s Disease: Old Acquisitions and Innovative Proposals

  2025cites this paper
• An In Vivo C57BL/6 Mouse Study Demonstrating Fine-Tuning of Serum and Brain-Derived Exosomes Reveal Therapeutic Potential of Phytochemical Ferulic Acid Against Alzheimer’s Disease

  2025cites this paper
• The HDL-Mimetic Peptide 4F Mitigates Vascular and Cortical Amyloid Pathology and Associated Neuroinflammation in a Transgenic Mouse Model of Cerebral Amyloid Angiopathy and Alzheimer’s Disease

  2025cites this paper
• High-Density Lipoprotein Mimetic Peptide 4F Reduces Toxic Amyloid-Beta Exposure to the Blood-Brain Barrier Endothelium in Alzheimer's Disease Transgenic Mice.

  2024cites this paper
• Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies

  2024cites this paper
• High-Density Lipoprotein Correlates with Cognitive Functioning in Schizophrenic Women

  2024cites this paper
• Correlation Analysis of ApoB, ApoA1, and ApoB/ApoA1 with Cortical Morphology in Patients with Memory Complaints

  2024cites this paper
• The study on cuproptosis in Alzheimer’s disease based on the cuproptosis key gene FDX1

  2024cites this paper
• Retardation of Aβ42 fibril formation by apolipoprotein A-I and recombinant HDL particles

  2023cites this paper
• Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease

  2023cites this paper
• [Anhedonia in mood disorders and somatic diseases: results of exploratory Mendelian randomization analysis].

  2023cites this paper
• Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia

  2023cites this paper
• Temporal pathway analysis of cerebrospinal fluid proteome in herpes simplex encephalitis

  2023cites this paper
• Therapeutic effect of human ApoA‐I‐Milano variant in aged transgenic mouse model of Alzheimer's disease

  2023cites this paper
• Longitudinal association of hypertension and dyslipidemia with cognitive function in community-dwelling older adults: the SONIC study

  2023cites this paper
• Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

  2023cites this paper
• Early Diagnosis of Alzheimer’s Disease with Blood Test; Tempting but Challenging

  2023cites this paper
• Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys

  2022cites this paper
• Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific

  2022cites this paper
• The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality

  2022cites this paper
• The small HDL particle hypothesis of Alzheimer’s disease

  2022cites this paper
• ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease

  2022cites this paper
• Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume

  2022cites this paper
• Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer’s Disease

  2022cites this paper
• Astrocytic MicroRNAs and Transcription Factors in Alzheimer’s Disease and Therapeutic Interventions

  2022cites this paper
• Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses

  2022cites this paper
• An Alzheimer’s disease gene prediction method based on ensemble of genome-wide association study summary statistics

  2022cites this paper
• Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.

  2022cites this paper
• The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review

  2022cites this paper
• Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs

  2021cites this paper
• Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases

  2021cites this paper
• Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42

  2021cites this paper
• Longitudinal trajectories of metabolic syndrome on different neurocognitive domains: a cohort study from the Taiwan biobank

  2021cites this paper
• Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia.

  2021cites this paper
• Effects of Apolipoprotein E Gene and Sex On Serum Lipid Profiles in Alzheimer's Disease

  2021cites this paper
• Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis

  2021cites this paper
• Exosomal Aβ-Binding Proteins Identified by “In Silico” Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease

  2021cites this paper
• Impact of Methyl-β-Cyclodextrin and Apolipoprotein A-I on The Expression of ATP-Binding Cassette Transporter A1 and Cholesterol Depletion in C57BL/6 Mice Astrocytes

  2021cites this paper
• Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer’s disease

  2021cites this paper
• The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEXTMAlz plus assay kit

  2021cites this paper
• Elevated Plasma Free Fatty Acid Susceptible to Early Cognitive Impairment in Type 2 Diabetes Mellitus

  2021cites this paper
• HDL Proteome and Alzheimer’s Disease: Evidence of a Link

  2020influential citation
• Lipid effects during antipsychotic drug treatment and their relevance for clinical outcomes

  2020cites this paper
• Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk

  2020cites this paper
• High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease

  2020cites this paper
• Association of serum apolipoprotein B with cerebrospinal uid biomarkers of Alzheimer’s disease pathology in elderly adults with subjective cognitive decline

  2020cites this paper
• Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance

  2020cites this paper
• BET bromodomains as novel epigenetic targets for brain health and disease.

  2020cites this paper
• The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1

  2020cites this paper
• Association of serum apolipoprotein B with cerebrospinal fluid Alzheimer’s disease biomarkers in patients with subjective cognitive decline

  2020cites this paper
• Alzheimer's disease in the gut—Major changes in the gut of 5xFAD model mice with ApoA1 as potential key player

  2020cites this paper
• Lifestyle intervention to prevent Alzheimer’s disease

  2020cites this paper
• Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology

  2020cites this paper
• Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

  2020cites this paper
• Decrease in Serum HDL-C Level Is Associated with Elevation of Blood Pressure: Correlation Analysis from the Korean National Health and Nutrition Examination Survey 2017

  2020cites this paper
• Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice

  2020cites this paper
• Association of serum apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in elderly adults with subjective cognitive decline

  2020cites this paper
• Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E

  2020cites this paper
• Blood lipid markers are associated with hippocampal viscoelastic properties and memory in humans

  2020influential citation
• The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease

  2020cites this paper
• Associations between CLU polymorphisms and memory performance: The role of serum lipids in Alzheimer's disease.

  2020cites this paper
• Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: a meta-analysis study.

  2019cites this paper
• How stress mediators can cumulatively contribute to Alzheimer’s disease An allostatic load approach

  2019cites this paper
• Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients

  2019cites this paper
• Plasma Biomarkers: Potent Screeners of Alzheimer’s Disease

  2019cites this paper
• Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.

  2019cites this paper
• Shared genetic architecture between metabolic traits and Alzheimer’s disease: a large-scale genome-wide cross-trait analysis

  2019cites this paper
• Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity

  2019cites this paper
• ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice

  2019cites this paper
• The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro

  2019cites this paper
• Investigating blood plasma levels of cytokines and amyloid-β as potential diagnostic biomarkers for preclinical Alzheimer’s disease

  2019cites this paper
• Association of plasma apolipoprotein B with cerebrospinal fluid Alzheimer’s disease biomarkers in patients with subjective cognitive decline

  2019cites this paper
• HDL from an Alzheimer's disease perspective

  2019cites this paper
• Relationship between mobility and cognitive impairment in patients with Alzheimer's disease.

  2019cites this paper
• Emerging roles for high‐density lipoproteins in neurodegenerative disorders

  2019cites this paper
• Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population

  2019cites this paper
• Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients

  2019cites this paper
• Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.

  2018cites this paper
• Identifying regulators of synaptic stability during normal healthy ageing

  2018cites this paper
• The role of lipoproteins on selected functions relevant to Alzheimer's Disease in human brain perivascular cells

  2018cites this paper
• Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.

  2018cites this paper
• Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions

  2018cites this paper
• Chapter 5 Lipids and Lipoproteins in Alzheimer ’ s Disease

  2018cites this paper
• Serum apolipoprotein A-1 concentrations and the prevalence of cardiovascular autonomic neuropathy in individuals with type 2 diabetes.

  2018cites this paper
• The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study

  2018cites this paper
• The total alkaloids from Coptis chinensis Franch improve cognitive deficits in type 2 diabetic rats

  2018cites this paper
• Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry

  2018cites this paper
• Identifying stage-specific markers of Alzheimer's disease using quantitative proteomics.

  2018cites this paper
• Association between olanzapine treatment and brain cortical thickness and gray/white matter contrast is moderated by cholesterol in psychotic disorders.

  2018cites this paper
• Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

  2017cites this paper
• Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease.

  2017cites this paper